Test Code IM Mononucleosis Screen
EHR Test Codes
| Test Code | Test Name | |
| Atlas | IM | Mono Screen |
| Cerner | Mononucleosis Screen |
Specimen Requirements
Preparation of Patient:
None
Container Type:
3 mL EDTA lavender top tube
Or
Gold Top 6mL SST Gel & Clot Activator Tube
Specimen Type:
Plasma or serum
Specimen Volume:
1.5 mL plasma or serum minimum .5 mL
Specimen Handling/Transport:
Transport ambient room temperature or refrigerated 2 - 8oC
Specimen Stability/Storage:
48 hours refrigerated 2 - 8oC
Performing Laboratory
Munson Healthcare Laboratories
Hematology Department
Priority, Frequency, & Turnaround
Priority:
Non-Emergent
Frequency:
24 hours 7 days a week
Turnaround:
0 - 1 days
Methodology
Immunochromatography
Reporting
Reference Range:
Negative
Critical Decision:
None
Clinical Significance
Infectious mononucleosis is caused by the Epstein-Barr virus, a member of the herpes group. The disease is seen most frequently in adolescents and young adults (15-24 years of age) but can occur in very young children (3 months) and older adults (70 years). In young children, EBV infection is asymptomatic or associated with undifferentiated febrile illness or mild upper respiratory infection. When an adolescent or adult contracts EBV, the IM syndrome develops. The most frequent symptoms are fever, sore throat, tender lymphadenopathy, anorexia, malaise, headache, and myalgia. Splenomegaly occurs in most patients. A macular, maculopapular or petechial rash occurs in up to 50% of the cases but most commonly in patients who have been treated with ampicillin. The mode of transmission appears to be intimate salivary contact, salivary contamination of eating and drinking vessels and airborne dissemination of EBV.
The results of the Mono II Rapid test should be interpreted in light of the clinical symptoms shown by the patient. The clinical and hematologic symptoms may occur before the serology is positive, and seronegative cases have been reported.
CPT Code(s)
86308